Piper Sandler has released a new research report, significantly upgrading the stock rating of biopharmaceutical company Tvardi Therapeutics Inc from "Neutral" to "Overweight".

老虎证券2026/07/09 04:10

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Meanwhile, the institution has significantly raised its target price, jumping from the previous $3 to $13, demonstrating strong confidence in the company's future prospects.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Piper Sandler has released a new research report, significantly upgrading the stock rating of biopharmaceutical company Tvardi Therapeutics Inc from "Neutral" to "Overweight".

You may also like

Crypto prices